全球體液採集和診斷市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測
市場調查報告書
商品編碼
1305164

全球體液採集和診斷市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

Global Body Fluid Collection And Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 254 Pages | 商品交期: 最快1-2個工作天內

價格

據預測,全球體液採集與診斷市場需求將從2022年的334.1億美元增至2030年的696.6億美元,2023-2030年的複合年成長率為9.62%。

體液採集和診斷是指採集、分析和檢測體內各種液體,如血液、尿液、唾液和腦脊液。進行這些檢測是為了診斷和監測各種病症,包括傳染病、癌症、代謝紊亂和荷爾蒙失調。體液採集和診斷涉及多個步驟,包括採集樣本、準備分析樣本和使用各種診斷技術分析樣本。體液採集可通過各種方法進行,包括靜脈穿刺、尿液採集和唾液採集。樣本採集完成後,將在實驗室進行處理並使用一系列診斷方法進行分析,如顯微鏡檢查、培養和分子診斷。這些檢查可提供有關體內是否存在特定物質的資訊,如蛋白質、激素和酶,以及是否存在異常細胞或微生物。體液採集和診斷檢測的結果可用於診斷病情、監測疾病進展和評估治療效果。這些檢測是現代醫療實踐的重要組成部分,在疾病預防和管理方面發揮著重要作用。

市場動態:

需要定期進行體液檢測的慢性疾病發病率不斷上升,推動了對體液採集和診斷技術的需求。液體活體組織切片和新一代測序等先進診斷技術的發展提高了體液採集和診斷的準確性和效率。患者和醫療服務提供者對微創手術的採用推動了對微創體液採集方法的需求。人們對早期疾病檢測重要性的認知不斷提高,這推動了對體液採集和診斷技術的需求,因為這些檢測有助於在疾病更易治療的早期階段發現疾病。許多國家政府正在實施促進早期疾病檢測和改善醫療設施的計劃,這推動了體液採集與診斷市場的成長。遠程醫療和虛擬會診已變得越來越普遍,使個人更容易在家中獲得體液採集和診斷服務。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構,評估全球競爭吸引力。此外,這些工具還對全球體液採集與診斷市場的各個細分市場進行了全面評估。體液採集與診斷行業的成長和趨勢為本研究提供了整體方法。

市場細分:

體液採集與診斷市場報告的這一部分提供了國家和地區層面細分市場的詳細數據,從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按樣本類型

  • 血液樣本
  • 唾液
  • 尿液
  • 腦脊液

按產品

  • 檢測/服務
  • 試劑盒和耗材
  • 儀器

按技術分類

  • 下一代測序(NGS)
  • 聚合酶鏈反應(PCR)
  • 螢光原位雜交(FISH)
  • 其他

按應用

  • 診斷與篩查
  • 診斷和監測
  • 治療決策

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太、拉丁美洲以及中東和非洲地區體液採集與診斷市場的當前和未來需求。此外,報告還重點關注了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。體液採集和診斷市場的主要參與者包括賽默飛世爾科技公司、Bio-Rad實驗室、Illumina公司、Guardant Health、QIAGEN、強生公司、美國實驗室公司控股、Biocept公司、F. Hoffmann-La Roche Ltd.、MDxHealth SA。本節包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

目 錄

第一章:前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張(USP)和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章:執行摘要

  • 市場亮點
  • 全球市場概況

第三章:體液採集與診斷- 行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按樣品類型的市場吸引力分析
    • 按產品的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 市場吸引力分析:按應用
    • 市場吸引力分析:按地區

第四章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章:COVID-19爆發的影響分析

第六章:全球體液採集和診斷市場分析:按樣品類型分類

  • 樣本類型概述
  • 歷史和預測數據
  • 按樣品類型分析
  • 血液
  • 唾液
  • 尿液
  • 腦脊液

第七章:全球體液採集和診斷市場分析:按產品分類

  • 產品概述
  • 歷史和預測數據
  • 按產品分析
  • 檢測/服務
  • 試劑盒和耗材
  • 儀器

第八章: 全球體液採集與診斷市場分析:按技術分類

  • 技術概述
  • 歷史和預測數據
  • 按技術分析
  • 下一代測序(NGS)
  • 聚合酶鏈反應(PCR)
  • 螢光原位雜交(FISH)
  • 其他

第九章:全球體液採集與診斷市場分析:按應用分類

  • 概述:按應用分類
  • 歷史和預測數據
  • 分析:按應用
  • 診斷與篩查
  • 診斷與監測
  • 治療決策

第10章:全球體液採集與診斷市場分析:按地區分類

  • 地區展望
  • 產品介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美地區銷售分析
    • 北美地區各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區各細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲各細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東及非洲其他地區銷售分析

第十一章:體液採集與診斷產品企業競爭格局

  • 體液採集與診斷市場競爭格局
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他發展

第十二章:公司概況

  • 頂級公司佔有率分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Bio-Rad Laboratories
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Illumina Inc
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Guardant Health
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • QIAGEN
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Johnson & Johnson
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Laboratory Corporation of America Holdings
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Biocept Inc
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • F. Hoffmann-La Roche Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • MDxHealth SA.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

*注:在公司概況中,財務細節和近期發展取決於可用性,如果是私營公司,則可能不包括在內。

Product Code: VMR112110594

The global demand for Body Fluid Collection And Diagnostics Market is presumed to reach the market size of nearly USD 69.66 BN by 2030 from USD 33.41 BN in 2022 with a CAGR of 9.62% under the study period 2023 - 2030.

Body fluid collection and diagnostics refer to the collection, analysis, and testing of various fluids within the body, such as blood, urine, saliva, and cerebrospinal fluid. These tests are performed to diagnose and monitor various medical conditions, including infectious diseases, cancer, metabolic disorders, and hormonal imbalances. Body fluid collection and diagnostics involve several steps, including the collection of the sample, preparation of the sample for analysis, and analysis of the sample using various diagnostic techniques. The collection of body fluids can be done through various methods, including venipuncture, urine collection, and saliva collection. Once the sample has been collected, it is processed and analyzed in a laboratory using a range of diagnostic methods, such as microscopy, culture, and molecular diagnostics. These tests can provide information related to the presence of specific substances in the body, such as proteins, hormones, and enzymes, as well as the presence of abnormal cells or microorganisms. The results of body fluid collection and diagnostics tests can be used to diagnose medical conditions, monitor the progression of any disease, and evaluate the effectiveness of treatments. These tests are an essential part of modern medical practice and play a vital role in disease prevention and management. 

Market Dynamics:

The increasing incidence of chronic diseases which require regular body fluid testing, is driving the demand for body fluid collection and diagnostics. The development of advanced diagnostic techniques and technologies, such as liquid biopsy and next-generation sequencing, has improved the accuracy and efficiency of body fluid collection and diagnostics. The adoption of minimally invasive procedures among patients and healthcare providers is driving the demand for less invasive body fluid collection methods. The awareness about the importance of early disease detection is scaling up, which is driving the demand for body fluid collection and diagnostics, as these tests can help detect diseases at an early stage when they are more treatable. Many governments are implementing initiatives to promote early disease detection and improve healthcare facilities, which is driving the growth of the body fluid collection and diagnostics market. Telemedicine and virtual consultations have become more prevalent, making it easier for individuals to access body fluid collection and diagnostic services from the comfort of their homes.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of body fluid collection and diagnostics. The growth and trends of body fluid collection and diagnostics industry provide a holistic approach to this study. 

Market Segmentation:

This section of the body fluid collection and diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Sample Type

  • Blood
  • Saliva
  • Urine
  • Cerebrospinal Fluid

By Product

  • Tests/Services
  • Kits & Consumables
  • Instruments

By Technology

  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In Situ Hybridization (FISH)
  • Others

By Application

  • Prognostics & Screening
  • Diagnostics & Monitoring
  • Therapeutic Decision Making

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Body Fluid Collection And Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the body fluid collection and diagnostics market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Illumina Inc, Guardant Health, QIAGEN, Johnson & Johnson, Laboratory Corporation of America Holdings, Biocept Inc, F. Hoffmann-La Roche Ltd., MDxHealth SA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BODY FLUID COLLECTION AND DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Sample Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Technology
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE

  • 6.1 Overview by Sample Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Sample Type
  • 6.4 Blood Historic and Forecast Sales by Regions
  • 6.5 Saliva Historic and Forecast Sales by Regions
  • 6.6 Urine Historic and Forecast Sales by Regions
  • 6.7 Cerebrospinal Fluid Historic and Forecast Sales by Regions

7 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Tests/Services Historic and Forecast Sales by Regions
  • 7.5 Kits & Consumables Historic and Forecast Sales by Regions
  • 7.6 Instruments Historic and Forecast Sales by Regions

8 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

  • 8.1 Overview by Technology
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Technology
  • 8.4 Next Generation Sequencing (NGS) Historic and Forecast Sales by Regions
  • 8.5 Polymerase Chain Reaction (PCR) Historic and Forecast Sales by Regions
  • 8.6 Fluorescence In Situ Hybridization (FISH) Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Prognostics & Screening Historic and Forecast Sales by Regions
  • 9.5 Diagnostics & Monitoring Historic and Forecast Sales by Regions
  • 9.6 Therapeutic Decision Making Historic and Forecast Sales by Regions

10 . GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE BODY FLUID COLLECTION AND DIAGNOSTICS COMPANIES

  • 11.1. Body Fluid Collection And Diagnostics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF BODY FLUID COLLECTION AND DIAGNOSTICS INDUSTRY

  • 12.1. Top Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Thermo Fisher Scientific Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Bio-Rad Laboratories
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Illumina Inc
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Guardant Health
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. QIAGEN
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Johnson & Johnson
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Laboratory Corporation of America Holdings
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Biocept Inc
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. F. Hoffmann-La Roche Ltd.
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. MDxHealth SA.
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Analysis by Sample Type (USD MN)
  •  Blood Market Sales by Geography (USD MN)
  •  Saliva Market Sales by Geography (USD MN)
  •  Urine Market Sales by Geography (USD MN)
  •  Cerebrospinal Fluid Market Sales by Geography (USD MN)
  •  Analysis Market by Product (USD MN)
  •  Tests/Services Market Sales by Geography (USD MN)
  •  Kits & Consumables Market Sales by Geography (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Analysis by Technology (USD MN)
  •  Next Generation Sequencing (NGS) Market Sales by Geography (USD MN)
  •  Polymerase Chain Reaction (PCR) Market Sales by Geography (USD MN)
  •  Fluorescence In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by Application (USD MN)
  •  Prognostics & Screening Market Sales by Geography (USD MN)
  •  Diagnostics & Monitoring Market Sales by Geography (USD MN)
  •  Therapeutic Decision Making Market Sales by Geography (USD MN)
  •  Global Body Fluid Collection And Diagnostics Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition

LIST OF FIGURES

  •  Research Scope of Body Fluid Collection And Diagnostics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Body Fluid Collection And Diagnostics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Sample Type
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Technology
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Sample Type (USD MN)
  •  Blood Market Sales by Geography (USD MN)
  •  Saliva Market Sales by Geography (USD MN)
  •  Urine Market Sales by Geography (USD MN)
  •  Cerebrospinal Fluid Market Sales by Geography (USD MN)
  •  Global Market Analysis by Product (USD MN)
  •  Tests/Services Market Sales by Geography (USD MN)
  •  Kits & Consumables Market Sales by Geography (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Global Market Analysis by Technology (USD MN)
  •  Next Generation Sequencing (NGS) Market Sales by Geography (USD MN)
  •  Polymerase Chain Reaction (PCR) Market Sales by Geography (USD MN)
  •  Fluorescence In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Application (USD MN)
  •  Prognostics & Screening Market Sales by Geography (USD MN)
  •  Diagnostics & Monitoring Market Sales by Geography (USD MN)
  •  Therapeutic Decision Making Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.